ICYMI: FDA Approves BKEMV, A Soliris Biosimilar, for aHUS and PNH
source: shutterstock.com

ICYMI: FDA Approves BKEMV, A Soliris Biosimilar, for aHUS and PNH

Have you ever heard of a biosimilar? A biosimilar is essentially a biologic that is highly similar in structure and function to a reference product. Although this might seem technical, it really…

Continue Reading ICYMI: FDA Approves BKEMV, A Soliris Biosimilar, for aHUS and PNH
The Impact of Artificial Intelligence: Predicting Visual Acuity in DME Following Vabysmo Treatment
Photo by Colin Lloyd on Unsplash

The Impact of Artificial Intelligence: Predicting Visual Acuity in DME Following Vabysmo Treatment

Artificial intelligence (AI) is changing the way we live. It seems rare to find an industry where AI has not made at least a preliminary impact. In politics, AI-generated cartoons…

Continue Reading The Impact of Artificial Intelligence: Predicting Visual Acuity in DME Following Vabysmo Treatment